Investigational Drug Information for BLD-0409
✉ Email this page to a colleague
What is the drug development status for BLD-0409?
BLD-0409 is an investigational drug.
There have been 5 clinical trials for BLD-0409.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 31st 2022.
The most common disease conditions in clinical trials are Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Fibrosis. The leading clinical trial sponsors are Blade Therapeutics and [disabled in preview].
There is one US patent protecting this investigational drug and forty-five international patents.
Summary for BLD-0409
| US Patents | 1 |
| International Patents | 45 |
| US Patent Applications | 9 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2022-05-31) |
| Vendors | 7 |
Recent Clinical Trials for BLD-0409
| Title | Sponsor | Phase |
|---|---|---|
| RESPIRARE Phase 2 Study of Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Blade Therapeutics | Phase 2 |
| Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers | Blade Therapeutics | Phase 1 |
| Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations | Blade Therapeutics | Phase 1 |
Clinical Trial Summary for BLD-0409
Top disease conditions for BLD-0409
Top clinical trial sponsors for BLD-0409
US Patents for BLD-0409
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BLD-0409 | ⤷ Try a Trial | Autotaxin inhibitors and uses thereof | SABRE THERAPEUTICS LLC (South San Francisco, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BLD-0409
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BLD-0409 | Australia | AU2016268250 | 2035-05-27 | ⤷ Try a Trial |
| BLD-0409 | Australia | AU2020239656 | 2035-05-27 | ⤷ Try a Trial |
| BLD-0409 | Australia | AU2022228098 | 2035-05-27 | ⤷ Try a Trial |
| BLD-0409 | Brazil | BR112017025420 | 2035-05-27 | ⤷ Try a Trial |
| BLD-0409 | Canada | CA2986759 | 2035-05-27 | ⤷ Try a Trial |
| BLD-0409 | China | CN107921048 | 2035-05-27 | ⤷ Try a Trial |
| BLD-0409 | Eurasian Patent Organization | EA036337 | 2035-05-27 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
